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Purpose: To assess the growth hormone (GH) response to the Wingate anaerobic test (WAnT) among children with short stature and suspected
GH deficiency. We hypothesized that the GH response to the WAnT would be similar to the GH response to a commonly used pharmacologic
provocation test.
Methods: Ten children (6 males and 4 females, age range 9.0–14.9 years) participated in the study. Each participant performed 2 tests: a standard
all-outWAnT, cycling for 30 s against constant resistance, and a standardized pharmacologic test (clonidine or glucagon). Blood samples for GHwere
collected before and 10, 30, 45, and 60 min after the beginning of exercise. In addition, we collected pre- and post-exercise blood lactate levels.
Results: There was a significant increase in GH levels after the WAnT, yet in 9 of 10 participants, this increase was below the threshold for GH
sufficiency. Peak GH after the WAnT was significantly lower compared to the pharmacologic GH provocation tests (with 9 of 10 demonstrating
GH-sufficient response).
Conclusion: The traditional WAnT cannot be used as a GH provocation test. Further research is needed to develop anaerobic exercise protocols
sufficient to promote GH secretion.
© 2016 Production and hosting by Elsevier B.V. on behalf of Shanghai University of Sport. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
The diagnosis of growth hormone (GH) deficiency in chil-
dren with short stature is complex and challenging. GH is
secreted from the pituitary gland in a pulsatile manner mainly
during periods of deep sleep at night, whereas duringmost of the
day GH levels are very low or even undetectable. Consequently,
a single random blood sample for circulating GH levels cannot
differentiate between a healthy and a GH-deficient child. To
overcome this, several provocation tests aimed at stimulating
pituitary GH release have been developed.1 Most of these tests
use pharmacologic agents2 and present possible patient risk (e.g.,
hypoglycemia). Moreover, the interpretation of a normal GH
response to pharmacologic stimuli may not necessarily reflect
physiological GH secretion. These confounding factors empha-
size the need for a more physiological stimulation test such as
exercise or for the use of constant-level circulating substances,
such as insulin-like growth factor 1 and its binding proteins, for
the diagnosis of childhood GH deficiency.3
Currently, GH deficiency is defined as failure to increase
serumGH concentrations above a predetermined threshold level
(e.g., 10 ng/mL, based on polyclonal hormonal assays) after a
minimum of 2 GH stimulation tests. Two tests are generally
required because false-negative responses (low GH levels in a
GH-sufficient child) may occur. Moreover, the definition of GH
deficiency in children may be even more challenging owing to
the continuum between complete and partial GH deficiency
based on the stimulated peak GH level (e.g., peak GH values of
7–10 ng/mLmay be considered partial GH deficiency; however,
peak GH levels below 5 ng/mL suggest more severe GH
deficiency).4 The artificial nature of pharmacologic provocation
tests and the possibility that these tests might not always reflect
GH under normal physiological conditions provided an impetus
for a more physiological test. It was further suggested that the
most important diagnostic role of “physiological” GH stimula-
tion tests such as exercise in children with suspected partial GH
deficiency. In these children, the response to pharmacologic
provocation might be partial, but the response to physiological
stimulation will be blunted. Therefore, children with a partial
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GH response to the first provocation test should undergo an
exercise test for GH secretion as the second preferred stimula-
tion test.
Previous studies have shown that only relatively long
(>10 min) and intense (above the lactic anaerobic threshold
(LAT)) aerobic exercise induces GH secretion.5The fact that this
type of exercise cannot truly be considered physiological
because it does not reflect the type of exercise that children
usually perform, combined with the complexity of such testing
(several laboratory visits to determine peak aerobic power, LAT,
and the relative testing intensity), led to an effort to use other
types of exercise to provoke GH release. Recent studies have
shown a significant increase in GH levels after the Wingate
anaerobic test (WAnT) (30 s of supramaximal cycle exercise
against resistance that is calculated relative to each individual’s
body mass) in young adults.6,7 This is promising because the
daily physical activity of children involves mainly spontaneous,
short, anaerobic-type exercise, suggesting that the GH response
to this kind of exercise will better represent the activity patterns
of children. In addition, this type of exercise stimulation test for
GH secretion requires only a single laboratory visit and as a
consequence is less complicated and time-consuming and more
cost-effective. Therefore, the aim of the present study was to
assess the GH response to theWAnT among children with short
stature and suspected GH deficiency. We hypothesized that the
GH response to theWAnT would be similar to the GH response
to a commonly used pharmacologic provocation test.
2. Materials and methods
2.1. Participants
Ten children (6 males and 4 females, age range 9.0–14.9 years,
body weight 34.5 ± 9.4 kg, body height 139.7 ± 10.4 cm, body
mass index 17.2 ± 2.9 kg/m2, body mass index percentile
30.7% ± 30.8%; mean ± SEM) participated in the study. Only 1
participant was overweight. Five participants were prepubertal, and
5 were at Tanner stages 2–3 for pubic hair. Participants were chil-
drenwhowere evaluated for short stature and impaired growth rate
in the endocrine clinic at the Meir Medical Center, Sackler School
of Medicine, Tel Aviv University, and were requested to perform
a provocation test for GH secretion. The study was approved by
the Meir Medical Center Institutional Review Board (Trial
registration number: NCT01934270), and appropriate informed
consent was obtained from all the participants and their parents.
2.2. Anaerobic test for GH secretion
The WAnT was performed using the Lode Corival cycle
ergometer (Lode B.V., Groningen, The Netherlands). Seat height
was adjusted to each participant’s satisfaction, and clips with
straps were used to prevent the feet from slipping off the pedals.
Each participant cycled 30 s against constant resistance. For
female participants resistance was set to 0.53/kg body weight
(≤14 years of age) or 0.67/kg body weight (≥14 years of age). In
male participants, resistance was set at 0.55/kg body weight (≤14
years of age) or 0.70/kg body weight (≥14 years of age).8 Par-
ticipants were instructed to pedal as fast as possible throughout
the test period and were verbally encouraged throughout the test.
In each test maximal power output, mean power output,
minimal power output, and fatigue index were measured. All
power output measurements are based on 5s averages that were
calculated by theWAnT computer software and were reported in
watts/kg. Maximal power output (peak power) was calculated
from the highest 5s work output. Mean power output, which
reflects the anaerobic capacity, was calculated as themean power
output throughout the 30 s of the test.Minimal power output was
calculated as the lowest 5s work output. Fatigue index was
calculated as the percentage of power output drop from the
maximal power output throughout the test.8
In a separate visit, each participant performed an additional
commonly used GH provocation test (i.e., clonidine test or
glucagon test) using standard protocols.
2.3. Blood sampling and analysis
Tests were performed in the morning after an overnight fast.
However, water was given ad libitum before testing to avoid
dehydration.An indwelling venous catheter was inserted 30 min
before the first blood draw, after allowing subjects to rest and sit
quietly. In the WAnT, blood samples were collected before and
10, 30, 45, and 60 min after the beginning of the exercise test.
Lactate levels were collected before, immediately after, and
10 min after theWAnT. In the clonidine test, blood samples were
collected before and 30, 60, 90, and 120 min after the beginning
of the exercise test. In the glucagon test, blood samples were
collected before and 60, 90, 120, 150, and 180 min after the
beginning of the exercise test. Blood samples were immediately
spun at 3000 rpm and at 4°C for 20 min. All serum specimens
from each individual for each test were analyzed in the same
batch by an experienced technician, who was blinded to the type
of provocation test and to the order of the samples.
2.3.1. GH
GH serum concentrations were determined by means of solid
phase, 2-site, chemiluminescent immunometric assay with the
Siemens IMMULITE 2000 immunoassay system (Siemens
Healthcare, Erlangen, Germany) using murine monoclonal
anti-GH antibody. Intra-assay coefficient of variability (CV)was
2.9%–4.6%, interassay CV was 4.2%–6.6%, and analytical sen-
sitivity was 0.01 ng/mL. Normal values in our laboratory are
0.1–7.5 ng/mL.
2.3.2. Lactate
Plasma lactate levels were measured by the COBAS
INTEGRA 400 system (Roche Diagnostics Ltd., Rotkreuz,
Switzerland) using the enzymatic colorimetric method. Intra-
assay CV was 0.7%–0.8%, interassay CV was 1.1%, and ana-
lytical sensitivity was 2 mg/dL. Normal values in our laboratory
are 4.5–19.8 mg/dL.
2.4. Statistical analysis
Two-way repeated-measure analysis of variance with
Bonferroni correctionswas used to assess the effect of theWAnT
on GH levels with time serving as the within-group factor and
type of provocative test as the between-group factor. Data are
presented as mean ± SEM. Significance was set at p < 0.05.
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3. Results
All participants completed theWAnT. Peak powerwas 7.9 ± 2.3
W/kg, power was 5.5 ± 1.1 W/kg, and fatigue index was
60.8% ± 17.6% (mean ± SEM).There was a significant increase in
GH levels after the WAnT (p < 0.015, Fig. 1). In all participants,
GHpeak was seen in the 10- or 30-min sample, except in 1 partici-
pant who experienced GHpeak before the WAnT. However, GHpeak
was significantly lower after theWAnT compared to the other GH
provocation test (p < 0.005, Fig. 2). Only 1 participant had GH
increase above 7.5 ng/mL after the WAnT (i.e., 15.3 ng/mL), and,
in this participant, GHpeak occurred before the exercise test. In
contrast, GHpeak was greater than 7.5 ng/mL in all participants
except 1 (i.e., 3.6 ng/mL) after the pharmacologic provocation
tests. There was no correlation between the GH response to the
WAnT and theGH response to the pharmacologic provocation test.
There was no difference in GH increase after the WAnT between
prepubertal and pubertal participants. There was no correlation
between any of the WAnT indices (peak power, mean power, and
fatigue index) and the GH response to the WAnT. There was a
significant increase in lactate levels after the WAnT (11.5 ± 2.0
mg/dL, 42.0 ± 7.9 mg/dL, and 53.3 ± 21.9 mg/dL before, imme-
diately after, and 10 min after, respectively; p < 0.005).
4. Discussion
Short stature is among the most common causes for referral
to the pediatric endocrinology clinic. The most common causes
of short stature are familial (genetic) short stature and delayed
(constitutional) growth, which are considered normal variants
of growth. A major goal in the evaluation of children with short
stature is to identify the fraction of children with pathologic,
genetic, systemic, and endocrine causes.9 GH deficiency is an
important treatable endocrine cause for short stature. Because
of the pulsatile nature of GH secretion, the diagnosis of GH
deficiency relies on the GH response to provocation tests and
additional information from auxological data and measure-
ments of insulin-like growth factor 1. However, provocative GH
testing has several limitations because it relies on GH assays of
variable accuracy, and the reproducibility of the tests has not
been adequately documented. Moreover, most pediatric endo-
crinologists define a “normal” GH response as a serum GH
concentration of >10 ng/mL, although the ideal threshold may
vary slightly with the laboratory and the assay used.9 To over-
come some of these limitations, a similar single monoclonal
GH assay has been used since 2010 for GH measurement
nationwide in Israel. As a result, the cutoff levels were changed;
a normal response is now defined as serum GH concentration of
>7.5 ng/mL and severe GH deficiency as GH levels <5 ng/mL.
With these cutoff levels, none of the participants in the present
study had a normal GH response to the WAnT (7 showed GH
response of <5 ng/mL and could be categorized as having
severe GH deficiency). In fact, only 1 subject demonstrated
normal GH levels; this level was measured before the exercise
stimulation, reflecting probably a spontaneous GH pulse or a
stress response to the testing procedure. Although one can
speculate that the blunted GH response to exercise reflects
“true” GH deficiency, the fact that all participants showed a
normal response to the pharmacologic provocation test suggests
that the WAnT cannot be used as a sufficient stimulus for GH
secretion. Moreover, a sufficient GH response to theWAnT was
also not seen in any of the 5 normal-height children (peak GH
2.6 ± 2.3 ng/mL (mean ± SEM), unpublished data), suggesting
that the WAnT is not a suitable GH stimulus even in normal-
height children.
The mechanism for the lack of GH response to the WAnT is
not clearly understood. Previous studies have indicated that the
aerobic exercise—induced GHpeak occurs about 25–30 min after
the start of the exercise, irrespective of the exercise duration,10
and occurs a few minutes earlier in females.11 In addition, it was
demonstrated that GHpeak after anaerobic exercise (interval
training) occurs earlier (10–15 min from the beginning of
exercise).12 This was the rationale for our GH sampling times of
10, 30, and 45 min after the start of exercise. Therefore, it is
possible, yet very speculative, that a different sampling timing
could detect a greater GH response.
Fig. 1. Changes in growth hormone (GH) level after the Wingate anaerobic
test. *p < 0.05, compared with pre-test.
Fig. 2. Pre-peak growth hormone (GH) levels after the Wingate anaerobic test
(WAnT) and commonly used pharmacologic GH provocation tests. *p < 0.01,
compared with GHpeak after WAnT.
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In addition, anticipation anxiety from the GH provocation test
may lead to an anticipation-related GHpeak before the GH provo-
cation test. Sometimes such a peak can prevent a sufficient GH
response to any stimulation test. In fact, this is 1 of the reasons
that 2 failed GH provocation tests are required before a diagnosis
of GH deficiency is made. Whether an anticipatory effect was
greater before theWAnT (compared to the pharmacologic test) as
a result of the stress from exercise itself is not known.
Peak and mean anaerobic power and fatigue index of the
present study participants were within normal values. There-
fore, it is unlikely that the cause of the reduced GH response
was the fact that the participants did not reach their maximal
effort. Moreover, there were no correlation between the WAnT
indices (peak power, mean power, and fatigue index) and the
GH response to the WAnT. Peak plasma lactate level after the
WAnT was relatively low (53.3 ± 21.9 mg/dL, which equals
5.9 ± 2.4 mmol/L). This is probably associated with the known
reduced glycolitic enzymatic activity and anaerobic capacity of
children.13 This is important because it was previously thought
that circulating GH levels increase only in response to exercise
intensity above, but not below, LAT,5 and that exercise loads of
75%–90% of maximal aerobic power yielded a greater GH
increase than milder loads.14 However, other studies have shown
that during constant exercise, increases in exercise intensity
(25%, 75%, 100%, 125%, and 175% of LAT) resulted in
increased GH secretion in a linear dose-dependent manner.15
Therefore, it is possible that the reduced GH response to the
WAnT in our study was related to the relatively lower anaerobic
capacity and lactate response of children.
5. Conclusion
In summary, although 30s supramaximal exercise better rep-
resents the daily pattern of physical activity in children (spon-
taneous, short, anaerobic-type exercise bursts), the GH
response to theWAnT cannot be used as a GH provocation test.
It is possible that a better anaerobic protocol for GH secretion
and 1 that would better mimic children’s activity patterns would
include several shorter 10–20 s maximal sprints that last alto-
gether about 10 min. Further research is needed to develop
other anaerobic exercise protocols that would be sufficient to
promote GH secretion.
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